Brainsway TMS device wins Israeli Ministry of Health approval

6 October 2011 (Last Updated October 6th, 2011 18:30)

Israel's Ministry of Health has approved Brainsway to market and sell the deep transcranial magnetic stimulation (TMS) device to four medical centres to treat neurological and psychopathological disorders.

Israel's Ministry of Health has approved Brainsway to market and sell the deep transcranial magnetic stimulation (TMS) device to four medical centres to treat neurological and psychopathological disorders.

Brainsway TMS systems is a noninvasive device which treats major depression, bipolar disorder and negative symptoms and cognitive impairment in schizophrenic patients.

Brainsway CEO Uzi Sofer said: "We are now working to update indications with the Israeli Ministry of Health to bring them more in line with the approvals that we've already received in Europe."